BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36474026)

  • 1. Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing.
    Hocking LJ; Andrews C; Armstrong C; Ansari M; Baty D; Berg J; Bradley T; Clark C; Diamond A; Doherty J; Lampe A; McGowan R; Moore DJ; O'Sullivan D; Purvis A; Santoyo-Lopez J; Westwood P; Abbott M; Williams N; ; Aitman TJ; Miedzybrodzka Z
    Eur J Hum Genet; 2023 Feb; 31(2):231-238. PubMed ID: 36474026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of clinically actionable variants from genome sequencing of families with congenital heart disease.
    Alankarage D; Ip E; Szot JO; Munro J; Blue GM; Harrison K; Cuny H; Enriquez A; Troup M; Humphreys DT; Wilson M; Harvey RP; Sholler GF; Graham RM; Ho JWK; Kirk EP; Pachter N; Chapman G; Winlaw DS; Giannoulatou E; Dunwoodie SL
    Genet Med; 2019 May; 21(5):1111-1120. PubMed ID: 30293987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EyeG2P: an automated variant filtering approach improves efficiency of diagnostic genomic testing for inherited ophthalmic disorders.
    Lenassi E; Carvalho A; Thormann A; Abrahams L; Arno G; Fletcher T; Hardcastle C; Lopez J; Hunt SE; Short P; Sergouniotis PI; Michaelides M; Webster A; Cunningham F; Ramsden SC; Kasperaviciute D; Fitzpatrick DR; ; Black GC; Ellingford JM
    J Med Genet; 2023 Aug; 60(8):810-818. PubMed ID: 36669873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the performance of a clinical genome sequencing program for diagnosis of rare genetic disease, seen through the lens of craniosynostosis.
    Hyder Z; Calpena E; Pei Y; Tooze RS; Brittain H; Twigg SRF; Cilliers D; Morton JEV; McCann E; Weber A; Wilson LC; Douglas AGL; McGowan R; Need A; Bond A; Tavares ALT; Thomas ERA; ; Hill SL; Deans ZC; Boardman-Pretty F; Caulfield M; Scott RH; Wilkie AOM
    Genet Med; 2021 Dec; 23(12):2360-2368. PubMed ID: 34429528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders.
    Wright CF; McRae JF; Clayton S; Gallone G; Aitken S; FitzGerald TW; Jones P; Prigmore E; Rajan D; Lord J; Sifrim A; Kelsell R; Parker MJ; Barrett JC; Hurles ME; FitzPatrick DR; Firth HV;
    Genet Med; 2018 Oct; 20(10):1216-1223. PubMed ID: 29323667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children.
    Balciuniene J; Liu R; Bean L; Guo F; Nallamilli BRR; Guruju N; Chen-Deutsch X; Yousaf R; Fura K; Chin E; Mathur A; Ma Z; Carmichael J; da Silva C; Collins C; Hegde M
    JAMA Netw Open; 2023 Jul; 6(7):e2326445. PubMed ID: 37523181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of variation in practice in the prenatal reporting of variants of uncertain significance by commercial laboratories: Need for greater adherence to published guidelines.
    Cornthwaite M; Turner K; Armstrong L; Boerkoel CF; Chang C; Lehman A; Nikkel SM; Patel MS; Van Allen M; Langlois S
    Prenat Diagn; 2022 Nov; 42(12):1514-1524. PubMed ID: 36068917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing using phenotype-based panels for genetic testing in inherited retinal diseases.
    Shah M; Shanks M; Packham E; Williams J; Haysmoore J; MacLaren RE; Németh AH; Clouston P; Downes SM
    Ophthalmic Genet; 2020 Aug; 41(4):331-337. PubMed ID: 32543920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing including targeted gene panel in a diverse clinical population of children with autism spectrum disorder: Findings and implications.
    Kalsner L; Twachtman-Bassett J; Tokarski K; Stanley C; Dumont-Mathieu T; Cotney J; Chamberlain S
    Mol Genet Genomic Med; 2018 Mar; 6(2):171-185. PubMed ID: 29271092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.
    Palmer EE; Schofield D; Shrestha R; Kandula T; Macintosh R; Lawson JA; Andrews I; Sampaio H; Johnson AM; Farrar MA; Cardamone M; Mowat D; Elakis G; Lo W; Zhu Y; Ying K; Morris P; Tao J; Dias KR; Buckley M; Dinger ME; Cowley MJ; Roscioli T; Kirk EP; Bye A; Sachdev RK
    Mol Genet Genomic Med; 2018 Mar; 6(2):186-199. PubMed ID: 29314763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing.
    Xue Y; Ankala A; Wilcox WR; Hegde MR
    Genet Med; 2015 Jun; 17(6):444-51. PubMed ID: 25232854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of proband and trio exome and genome analysis in rare disease: A micro-costing study.
    Mordaunt DA; Gonzalez FS; Lunke S; Eggers S; Sadedin S; Chong B; Dalziel K; Stark Z; Goranitis I
    Genet Med; 2024 Apr; 26(4):101058. PubMed ID: 38164890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.
    Lionel AC; Costain G; Monfared N; Walker S; Reuter MS; Hosseini SM; Thiruvahindrapuram B; Merico D; Jobling R; Nalpathamkalam T; Pellecchia G; Sung WWL; Wang Z; Bikangaga P; Boelman C; Carter MT; Cordeiro D; Cytrynbaum C; Dell SD; Dhir P; Dowling JJ; Heon E; Hewson S; Hiraki L; Inbar-Feigenberg M; Klatt R; Kronick J; Laxer RM; Licht C; MacDonald H; Mercimek-Andrews S; Mendoza-Londono R; Piscione T; Schneider R; Schulze A; Silverman E; Siriwardena K; Snead OC; Sondheimer N; Sutherland J; Vincent A; Wasserman JD; Weksberg R; Shuman C; Carew C; Szego MJ; Hayeems RZ; Basran R; Stavropoulos DJ; Ray PN; Bowdin S; Meyn MS; Cohn RD; Scherer SW; Marshall CR
    Genet Med; 2018 Apr; 20(4):435-443. PubMed ID: 28771251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis.
    Mone F; Eberhardt RY; Hurles ME; Mcmullan DJ; Maher ER; Lord J; Chitty LS; Dempsey E; Homfray T; Giordano JL; Wapner RJ; Sun L; Sparks TN; Norton ME; Kilby MD
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):509-518. PubMed ID: 33847422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurogenetic fetal akinesia and arthrogryposis: genetics, expanding genotype-phenotypes and functional genomics.
    Ravenscroft G; Clayton JS; Faiz F; Sivadorai P; Milnes D; Cincotta R; Moon P; Kamien B; Edwards M; Delatycki M; Lamont PJ; Chan SH; Colley A; Ma A; Collins F; Hennington L; Zhao T; McGillivray G; Ghedia S; Chao K; O'Donnell-Luria A; Laing NG; Davis MR
    J Med Genet; 2021 Sep; 58(9):609-618. PubMed ID: 33060286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.